No reviewed warning list
As of October 1, 2026, ipamorelin has no FDA-reviewed medical information listing who must avoid it.
As of October 1, 2026, the reviewed studies had not tested ipamorelin in pregnancy, breastfeeding or children.
Ask a licensed clinician, such as a doctor or nurse practitioner, about your own situation.
Missing studies cannot give an answer about your personal risk.
Details to raise directly
This guide groups the FDA’s concerns into details to discuss. This is our reading of those concerns, not an official ipamorelin warning list.
The FDA’s concerns give reason for caution around diabetes, high blood sugar, cancer history and plans for pregnancy.
Discuss those details with a licensed clinician. Add your medicines, supplements, past reactions and the health change you hope for.
Ask what remains unknown
The FDA found no published animal studies on harm from ipamorelin over time, damage to genes, cancer risk or effects on pregnancy. Genes are the instructions inside cells.
Its concerns about fertility and pregnancy are theoretical; they are not proof that ipamorelin causes those harms.
Ask which concerns have been seen in people, which are possibilities suggested by other evidence, and which have not been studied.